MedPath

Efficacy of Tranexamic Acid on Blood Loss During Rhinoplasty

Phase 3
Conditions
Rhinoplasty.
Registration Number
IRCT20111219008458N2
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Without any systemic disease
ASA I category

Exclusion Criteria

Drug abuser or addict
Renal or Liver failure
Hemostatic disorders
History of convulsion
Hypersensitivity to Tranexamic Acid
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of bleeding. Timepoint: Before intervention, Immediately after intervntion. Method of measurement: Hemoglobin concentration and blood volume in suction.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath